Living-cell Wound Care Product Improves Reimbursement
Apligraf, the only cell-based product with Food and Drug Administration approval for the treatment of both diabetic foot ulcers and venous leg ulcers, has established improved coverage from multiple payors.
New Shape-to-Fit Skin Barrier Introduced
The FormaFlex Shape-to-Fit Skin Barrier includes a skin barrier formulation, non-elastic barrier backing, and tactile ridges, and allows a customized fit around various stoma shapes and sizes.
Regenerative Tissue Matrix Gains Medicare Coverage
In 8 Midwestern states, Medicare beneficiaries will now have access to the Graftjacket regenerative tissue matrix for the treatment of neuropathic diabetic foot ulcers.
Registration is now open for the 27th Annual Clinical Symposium on Wound Care, October 20-23, 2012, at Caesars Palace in Las Vegas, Nevada. We’ll see you there!
From the pages of Advances in Skin & Wound Care
Earn CE/CME credit by reading this peer-reviewed, continuing education article from Advances in Skin & Wound Care
and taking the test.
Evidence for Interventional Procedures as Adjunct Therapy in the Treatment of Shingles Pain
Heidi J. Shannon BSN-BC; Julie Anderson PhD, RN; and Jayant S. Damle MD